INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 55 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q4 2015. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $13,000 | +85.7% | 3,220 | +97.5% | 0.00% | 0.0% |
| Q4 2016 | $7,000 | -75.0% | 1,630 | -66.2% | 0.00% | -66.7% |
| Q2 2016 | $28,000 | +460.0% | 4,829 | +535.4% | 0.00% | +200.0% |
| Q4 2015 | $5,000 | -54.5% | 760 | -42.8% | 0.00% | 0.0% |
| Q3 2015 | $11,000 | -77.1% | 1,328 | -55.3% | 0.00% | -75.0% |
| Q2 2015 | $48,000 | – | 2,974 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|